Charles Schwab Investment Management »

Contineum Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $829k 43k 19.14
2024-06-30 $912k 52k 17.61

More positions owned by Charles Schwab Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us S (FNDA)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Broadcom (AVGO)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Schwab Strategic Tr Fundamental Intl (FNDF)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Charles Schwab Investment Management

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Johnson & Johnson
Perceptive Advisors
Franklin Resources
Versant Venture Management
Hillhouse Capital Advisors
Samsara BioCapital
Vanguard Group
Altium Capital Management
BlackRock
BlackRock
Baker Bros. Advisors
Casdin Capital
Squarepoint Ops
Geode Capital Management

View all funds holding Contineum Therapeutics